Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Ark Therapeutics
Ark Therapeutics
Activities:
Research & Development
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Ark Therapeutics makes a promotion
David Venables will become ceo on 1 August
Pharmaceutical
New head of business development for Ark
Kassim Kolia will build firm’s manufacturing services business at Finland facility
Research & Development
David Venables joins Ark Therapeutics
As executive director of manufacturing services
Manufacturing
Ark agrees manufacturing deal with Glasgow University
To support development of gene-therapy programme for treating vein graft failure
Manufacturing
Ark and PsiOxus sign manufacturing agreement
To support the development of colorectal cancer treatment
Research & Development
Ark-led consortium wins €5.3m grant
To fund project that combines adenoviral-delivered gene therapeutics and stem cell therapy
Research & Development
Ark wins funding to progress lentiviral technology
Grants awarded by agencies in Finland
Subscribe now